Serologic survey for markers of hepatitis B infection in dermatologists. 1985

J J Leyden, and J G Smith, and D K Chalker, and T H Rea, and K J Tomecki, and M Levitan

A serologic survey for markers of hepatitis B virus (HBV) infection was conducted in 593 dermatologists. Serologic evidence for previous infection was found in 15.4%, indicating that dermatologists are an at-risk population comparable to many other specialties of medicine. Dermatologists with a history of blood transfusion, tattoo, and homosexuality had an increased prevalence of serologic markers for HBV. The type of practice, extent of surgery, and glove-wearing practices did not correlate with HBV serologic markers.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009784 Occupational Diseases Diseases caused by factors involved in one's employment. Diseases, Occupational,Occupational Illnesses,Disease, Occupational,Illnesse, Occupational,Illnesses, Occupational,Occupational Disease,Occupational Illnesse
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D001803 Blood Transfusion The introduction of whole blood or blood component directly into the blood stream. (Dorland, 27th ed) Blood Transfusions,Transfusion, Blood,Transfusions, Blood
D003880 Dermatology A medical specialty concerned with the skin, its structure, functions, diseases, and treatment.
D005260 Female Females
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006510 Hepatitis B Antibodies Antibodies to the HEPATITIS B ANTIGENS, including antibodies to the surface (Australia) and core of the Dane particle and those to the "e" antigens. Anti-Australia Antigens,Anti-HBAg,Anti-Hepatitis B Antigens,Anti HBAg,Hepatitis B Virus Antibodies,Anti Australia Antigens,Anti Hepatitis B Antigens,Antibodies, Hepatitis B,Antigens, Anti-Australia,Antigens, Anti-Hepatitis B,B Antibodies, Hepatitis,B Antigens, Anti-Hepatitis,HBAg, Anti
D006512 Hepatitis B Core Antigens The hepatitis B antigen within the core of the Dane particle, the infectious hepatitis virion. HBcAg,Hepatitis B Core Antigen

Related Publications

J J Leyden, and J G Smith, and D K Chalker, and T H Rea, and K J Tomecki, and M Levitan
January 1981, Annual review of medicine,
J J Leyden, and J G Smith, and D K Chalker, and T H Rea, and K J Tomecki, and M Levitan
February 1986, Seminars in liver disease,
J J Leyden, and J G Smith, and D K Chalker, and T H Rea, and K J Tomecki, and M Levitan
January 1990, Revista de sanidad e higiene publica,
J J Leyden, and J G Smith, and D K Chalker, and T H Rea, and K J Tomecki, and M Levitan
February 1994, Atencion primaria,
J J Leyden, and J G Smith, and D K Chalker, and T H Rea, and K J Tomecki, and M Levitan
April 1985, Medicina clinica,
J J Leyden, and J G Smith, and D K Chalker, and T H Rea, and K J Tomecki, and M Levitan
April 1984, Revista clinica espanola,
J J Leyden, and J G Smith, and D K Chalker, and T H Rea, and K J Tomecki, and M Levitan
January 1987, Gematologiia i transfuziologiia,
J J Leyden, and J G Smith, and D K Chalker, and T H Rea, and K J Tomecki, and M Levitan
October 1983, Presse medicale (Paris, France : 1983),
J J Leyden, and J G Smith, and D K Chalker, and T H Rea, and K J Tomecki, and M Levitan
January 1978, Scandinavian journal of gastroenterology,
J J Leyden, and J G Smith, and D K Chalker, and T H Rea, and K J Tomecki, and M Levitan
January 2007, Clinical laboratory,
Copied contents to your clipboard!